Patients with epilepsy, psychosis and poor liver function should be cautious.
character
Announce
edit
This product is colorless crystal, white or almost white crystalline powder, odorless;Gradual change in light.
This product is easily soluble in water, slightly soluble in ethanol, and very slightly soluble in ether.
melting point
The melting point of this product (general rule 0612) is 170~173 ° C.
Specifications
Announce
edit
Tablets: 50mg, 100mg, 300mg;
Injection: 2ml: 50mg, 2ml: 100mg.[5-6]
Usage and dosage
Announce
edit
1. Oral: 0.1~0.3g once for adults, 0.2~0.6g per dayAcute miliary pulmonary tuberculosisOr tuberculous meningitis, 0.2~0.3g once, three times a day.
2. Intravenous injection or intravenous drip: 0.3-0.6g once, plus 5% for more severe infiltrating tuberculosis, extrapulmonary active tuberculosis, etcGlucose InjectionorIsotonicsodium chloride injection 20~40mL, slowly inject.Or add 250~500ml of intravenous infusion.
3、Intramuscular injection: It is mostly used for patients who cannot take orally, and the dose is the same as that of oral administration.
5. Pertussis: 10~15mg/kg per day, divided into three times.
6. Wheaty swelling: 4~10mg/kg, divided into three times a day.
7. Local (intrapleural injection therapyFocalTuberculosis, etc.): 50-200mg once.
Adverse reactions
Announce
edit
The treated amount of isoniazid has less adverse reactions, less toxicity, headache, dizziness and other minor reactions.Higher dose (more than 6mg/kg per day) common peripheralneuritis, paresthesia of limbsReflection disappears, muscleParesisandinsaneTherefore, those with epilepsy, alcoholism and mental illness history should use it carefully.These symptoms are related to vitamin B6 deficiency.Its mechanism may be that isoniazid is similar to vitamin B6 in structure, while competing for the sameEnzyme systemOr combined into hydrazone, excreted by urine, which reduces the utilization of vitamin B6 and causes amino acidsMetabolic disorderAnd produce peripheral neuritis.When vitamin B6 is deficientglutamategenerateGABAThe central nervous system is blockedInhibitory transmitterGABA reduction, resulting inCentral excitation, insomnia, restlessness, and evenconvulsions, InductionSchizophreniaandEpilepsy。It can be treated or prevented by taking vitamin B6 together.High dose isoniazid can damage the liver, causingtransaminaseTemporary increase.Fast acetylation, over 35 years old and alcoholism are more likely to occur.Therefore, liver function should be checked regularly during medication,hepatopathyPatients should use it with cautionhepatitis, it is strictly prohibited to continue using.
becauseVasculitisCaused byasthmaOr lung damage is rare.China reported a case of asthma on the third day after taking 300mg of the drug daily, and the asthma disappeared on the second day after stopping the drug.Another case reported that Lufreu's syndrome occurred 13 days after medication.
Peripheral neuritis is more common in patients with slow acetylation, and has a significant relationship with the dose.The incidence rate was 1%~2%, which most often occurred in the third week after treatment.Symptoms often start from the feet and lower limbs, with abnormal sensation first,Muscle strengthHypoplasia, numbness, hyporeflexia, subsequent pain, severe casesMuscular atrophyandAtaxia,central nervous systemThe symptoms of infringement are dizziness, headache, restlessness, euphoria, insomniaRetrobulbar neuritis, red and greenColor vision disorder, BrainDysfunctionAnd convulsions.Temporary excitability, moodiness, anxiety, euphoria, depression, separation of concept from reality may also occur,alcoholismPatients are more common.
exceptanorexia, nausea and mild epigastric pain, no serious reaction.Oral mucosal reaction is rare after the addition of vitamin B6.Sometimes the patient is constipated because he is in bed.The adverse liver reactions caused by this product are not uncommon, and are related to age, dose, acetylation type, combined medication and other factors.Can happen to those who take medicine for a long timeFatty liver。
It may cause nodular vasculitis and invade the kidney, and may also occurGlomerulonephritis。Renal insufficiencyEighty five percent of patients need good dose control and renal function examination.
A few reports due to lack of 5-phosphoric acidVitamin B6 causes iron utilization disorder (Sidero astric) anemia.Over the years, China has reported individual cases.There are also individual occurrencesAntinuclear antibodyA positive report.
Endocrine and metabolism
diabetesPeople should use this product for treatment, especially at the same timeAdrenocortical hormoneClose observation and control shall be carried out.Otherwise, diabetes will worsen.Occasionally, it is reported that due to this productGonadotropinThe formation ofCushing syndrome, accompanied by increased appetite, overweight andPurple stripe。There are also female breast and female breast after several months of treatmentMenstrual disorderAnd amenorrhea.
Anaphylactic reaction
Rashes (2%), fever (1-2%)jaundice(0.6%).Isoniazid can cause rheumatic syndrome, which is manifested asArthralgiaAnd ankylosis, often starting from the proximal finger joint and later invadingMetacarpophalangeal joint, wrist, elbow and othersLarge articulationAnd the spine.Erythema caused by isoniazidLupus like syndromeThe serious symptoms ofarthritis、rheumatic feverOr accompanied by fever, pleurisy and leukopenia, and drug withdrawal is required.
Drug interaction
Announce
edit
1. Drinking alcohol every day when taking isoniazid is easy to cause the liver induced by this productToxic reactionAnd accelerate the metabolism of the product.Therefore, the dosage of the product must be adjusted and closely observedHepatotoxicitysign.Patients should be advised to avoid alcoholic beverages during medication.
2. AndAdrenocortical hormone(In particularPrednisolone)When used together, it can increase the metabolism and excretion of the product in the liver, resulting inBlood concentrationThe effect of reduction is more significant in fast acetylation patients, and the dosage should be adjusted appropriately.
3、Anticoagulant(e.gcoumarinOr ninhydrin diketone derivatives) when used together with this product, the anticoagulant effect is enhanced due to inhibition of the enzyme metabolism of anticoagulants.
4. Isoniazid isVitamin B6OfAntagonistIt can increase the output of vitamin B6 through the kidney, which is easy to cause peripheral neuritis.Those taking vitamin B6 at the same time should increase the dosage as appropriate.
5. It should not be used together with other neurotoxic drugs to avoid increasingneurotoxicity。
6. AndCycloserineCan be increased when used togethercentral nervous systemAdverse reactions (such asdizzyorLethargy), the dosage should be adjusted, and the central nervous system should be closely observedSystemic toxicitySigns, especially for patients engaged in work requiring high sensitivity.
7. AndEthionium、Pyrazinamide、Li FupingWhen other antituberculosis drugs with hepatotoxicity are used together, the hepatotoxicity of the product can be increased, especially for those with liver function damage or those with fast and slow acylation of isoniazid. Therefore, it should be avoided to use together or closely follow up for signs of hepatotoxicity in the first three months of the course of treatment.
8. SuppressablecarbamazepineThe metabolism of, make its blood drug concentration increase, cause toxic reaction;Carbamazepine can induce isoniazidmicrosomeMetabolism, forming an intermediate with hepatotoxicitymetaboliteIncrease.
9. AndAcetaminophenWhen used together, isoniazid can induceHepatocytePigment P-450 increases the amount of toxic metabolites formed by the former, which can increase the hepatotoxicity andNephrotoxicity。
10. AndAlfentanilWhen used together, isoniazid isHepatic drug enzyme inhibitor, can prolong the effect of alfentanil;AndDisulfiramCombined use can enhance the role of the central nervous system, resulting in dizziness, uncoordinated movement, irritability, insomnia, etc;AndEnfluraneCombined use can increase the formation of inorganic fluoride metabolites with nephrotoxicity.
11. Not suitable forTong KangzuoorMiconazoleWhen used together, the blood concentration of the latter two drugs can be reduced.
12. With phenytoin sodium oraminophyllineWhen used together, it can inhibit the metabolism of both in the liver, resulting inPhenytoin sodiumOr the blood concentration of aminophylline increases, so the dosage of phenytoin sodium or aminophylline should be properly adjusted when the product is used successively or in combination with both.
13. Inaccessibilityephedrine、belladonnaTake it at the same time to avoid or increase adverse reactions.
Isoniazid is also the firstAntidepressantsHowever, it was withdrawn from the market due to its strong hepatotoxicity.
Antibacterial
IsoniazidMycobacterium tuberculosisIt is highly selective and has strong antibacterial effect. The concentration of 0.025-0.05mg/L in the test tube can inhibit bacteria, and the higher concentration of 10mg/L can inhibit bacteriaBreeding periodBacteriaBactericidal action。For tubercle bacillus in quiescent period, increasing drug concentration or prolonging contact time can also have bactericidal effect.It has the same killing effect on Mycobacterium tuberculosis both inside and outside the cell.Isoniazid is easy to produce drug resistance when used alone, and can be delayed when used in combinationDrug resistanceAnd enhance the curative effect.Isoniazid and other anti tuberculosis drugsCross resistance。
Although the mechanism of action of isoniazid has been studied in detail, it is not very clear.One is that isoniazid is converted into isoniazidnicotinic acid,Isonicotinic acidNicotinicAntimetabolite, instead of niacin, bound toNAD+, Deceived NAD+It cannot catalyze normal redox reaction.Another argument is that isoniazid inhibits C by blocking the action of desaturasetwenty-fourAnd Ctwenty-sixSaturated fatty acid conversion to Ctwenty-fourAnd Ctwenty-sixUnsaturated fatty acids, which are most likely to beMycotic acidMycoic acid, the precursor of mycotic acid, is a key component of bacterial cell wall. Inhibiting the biosynthesis of mycotic acid will lead to the loss of acid resistance of bacteria. This mechanism fully demonstrates the selectivity of isoniazid on the role of cell wall of Mycobacterium tuberculosis.
clinical
This product is for treatmenttuberculosisIt is the first choice drug for all types of tuberculosis, such as tuberculosis of lung, lymph, bone, kidney, intestine, tuberculous meningitispleurisyandperitonitisEtc.In order to prevent and delay the emergence of drug resistance, it should be combined with other first-line anti tuberculosis drugs.For acuteMiliary tuberculosisAnd tuberculous meningitis should be increased. If necessaryIntravenous drip。Isoniazid can be used for prevention andActive pulmonary tuberculosisPeople contacted by patients.
Toxicology
1. MildGastrointestinal reactions, such as loss of appetite, nausea, vomiting, abdominal pain, constipation, etc., pregnant women should use with caution.
2. There is often peripheral neuritis.
3. Do not use if there is liver damage or poor liver function.
4. Allergic reaction, drug fever and rash may occur.
2、Vitamin B6Preventablenervous systemFor the occurrence of reaction, the daily dosage shall be 10-20mg, which shall be taken once or twice, but it shall not be used as a routine.Meet isoniazidacute poisoningA large dose of vitamin B6 can be antagonized, and other symptomatic treatment is required.
3. You can also take 300mg once a day or twice a week, 0.6-0.8g onceAdministrationThe method can improve the curative effect and reduce the incidence of adverse reactions.
5. Pay attention to inspection during medicationliver function。People with poor liver functionmental diseaseandepilepsyPatients with medical history should use it with caution.
6. Pregnant women should use it with caution.
7、Antacidin especialAluminium hydroxideIt can inhibit the absorption of the product and should not be taken together.
A brief history of research
Announce
edit
In 1912, isoniazid was originallyBraggOfCharles University Hans Meyer and Josef Mally, graduate students of the Department of Chemistry (then Germany), synthesized it in 1912 when they were doing their doctoral thesis.They are totally unaware of the great medicinal value of their products.After being forgotten for about 40 years, researchers from Ross and Squibb in the United States and Bayer in West Germany independently found that isoniazid has extremely strong resistanceTuberculosis bacteriaActivity.
In 1951, the clinical trial of isoniazid began in New York in 1951.
In 1952, isoniazid was first listed in the United States by Roche,Trade nameRemifeng.
After years of use, it has been found that isoniazid has strong bactericidal power, high selectivity and few side effects.In particular, it is cheap and can be affordable for people in some poor areas.The sterilization characteristic of isoniazid is that it can inhibit the synthesis of mycotic acid components in the wall of tuberculosis bacteria, so thatMycobacterium tuberculosisLoss of multiple abilities (acid resistance, proliferation,Hydrophobicity)When death occurs, isoniazid can also interact with tuberculous bacteriacoenzymeCombination, interferenceDeoxyribonucleic acidandRibonucleic acidSynthesis, so as to achieve the purpose of killing tuberculosis.The study also found that isoniazid had a stronger effect on tuberculosis bacteria with strong metabolic activity.
In this nearly 50 year history of use, although some patients infected with tuberculosis have developed drug resistance, the vast majority of doctors still believe that it is an indispensable main drug for the treatment of tuberculosis.
Reference value for drainage parameter calculation (XlogP): None
Number of hydrogen bond donors: 2
Number of hydrogen bond receptors: 3
Number of rotatable chemical bonds: 1
Number of tautomers: 4
Topological molecular polar surface area: 68
Number of heavy atoms: 10
Surface charge: 0
Complexity: 120
Number of isotope atoms: 0
Determine the number of atomic structure centers: 0
Number of uncertain atomic structure centers: 0
Determine the number of chemical bond structure centers: 0
Number of uncertain chemical bond structure centers: 0
Number of covalent bond units: 1[1]
Overtreatment
Announce
edit
performance
In addition to the above adverse reactions, the main manifestations are convulsions, confusion, coma, etc., which may occur if not handled in timeAcute liver necrosis。
3. Adopt short effectBarbitalPreparations andvitamin B6 Intravenous administration.The dose of vitamin B6 is 1mg of vitamin B6 for every 1mg of isoniazid. If the dose of isoniazid is unknown, 65g of vitamin B can be given every 30 minutes until the convulsion stops and the patient regains consciousness.Then gastric lavage should be carried out within 2-3 hours after taking the product.
6. AdoptOsmotic diureticAnd continue to use it after the clinical symptoms have been improved to promote the excretion of isoniazid and prevent the recurrence of poisoning symptoms.
7. Patients with severe poisoning should be given blood as soon as possibleHemodialysisWhen hemodialysis is not availableperitoneal dialysis, shared at the same timediuretic。
1. Take about 10mg of this product, put it in a test tube, add 2mL of water to dissolve it, and then add ammonia to makesilver nitrateTest solution1mL, bubbles and black turbidity will occur, and a silver mirror will be generated on the tube wall.
2. In the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.
3. The infrared absorption spectrum of this product should be consistent with the control spectrum (spectrum set 166 figure).
inspect
Announce
edit
PH
Take 0.50g of this product, add 10mL of water to dissolve it, and then measure according to the law (general rule 0631). The pH value should be 6.0~80。
Clarity and color of solution
Take 1.0g of this product and add 10mL of water to dissolve it. The solution should be clear and colorless. If it appears turbidTurbidity standard solution(General Rule 0902, the first method) shall not be more concentrated. If color is developed, it shall be compared with the control solution of the same volume (for color comparisonpotassium dichromateLiquid 3.0mL for color comparisoncopper sulphateLiquid 0.10mL, diluted with water to 250mL), and shall not be deeper.
Test solution: Take an appropriate amount of this product, add solvent to dissolve it and dilute it quantitatively to prepare a solution containing about 0.1g per 1mL.
Reference solution: TakeHydrazine sulfateA proper amount of reference substance is dissolved in solvent and diluted quantitatively to prepare a solution containing about 80 µ g (equivalent to 20 µ g of free hydrazine) per 1mL.
System suitabilitysolution: Take appropriate amount of isoniazid and hydrazine sulfate, add solvent to dissolve and dilute them to prepare a mixed solution containing 0.1g of isoniazid and 80 µ g of hydrazine sulfate per 1mL.
Chromatographic conditions: silica gel GLaminate, withIsopropanol-Acetone (3:2) is the developing agent.
System suitability requirements: the spots of free hydrazine and isoniazid shown in the system suitability solution should be completely separated, the ruler value of free hydrazine is about 0.75, and the ruler value of isoniazidRfThe value is approximately 0.56.
Determination method: take 5 µ L each of the test solution, the reference solution and the system suitability solution, dab them on the same thin-layer plate, develop them, dry them in the air, and spray them with ethanolP-DimethylaminobenzaldehydeTest solution, check after 15 minutes.
Limit: No yellow spots shall appear in front of the main spot of the test solution and the corresponding position of the main spot of the reference solution.
Test solution: take a proper amount of this product, add water to dissolve and dilute it to make a solution containing about 0.5mg per 1mL.
Reference solution: Accurately measure 1mL of the test solution, place it in a 100mL volumetric flask, dilute it with water to the scale, and shake it well.
System suitability requirements:Theoretical plate numberNot less than 4000 calculated according to isoniazid peak.
Determination method: Precisely measure the test solution and the reference solution and inject them into the liquid chromatograph respectively, and record the retention time of the chromatogram to the main component peak 3.5 times.
Limit: If there is an impurity peak in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.35 times (0.35%) of the main peak area of the reference solution, and the sum of the areas of each impurity peak shall not be greater than the main peak area of the reference solution (1.0%).
Loss on drying
Take the product and dry it at 105 ° C to constant weight, and the weight loss shall not exceed 0.5% (general rule 0831).
Ignition residue
Take 1.0g of this product and check it according to the law (general rule 0841). The residual residue shall not exceed 0.1%.
heavy metal
Take the residue left under the item of burning residue and check it according to law (the second method of General Rule 0821). The content of heavy metals shall not exceed 10% per million.
sterile
Take the product, dissolve it with suitable solvent, and then apply the filmFiltration methodTreatment and inspection according to law (general rule 1101) shall meet the requirements.(For sterile subpackaging)
Assay
Announce
edit
Determine according to the method of high performance liquid chromatography (general rule 0512).
Test solution
Take an appropriate amount of this product, weigh it precisely, add water to dissolve it and dilute it quantitatively to prepare a solution containing about 0.1mg per 1mL.
Reference solution
Take an appropriate amount of isoniazid reference substance, weigh it precisely, add water to dissolve it and dilute it quantitatively to prepare a solution containing about 0.1mg per 1mL.
Chromatographic conditions and system suitability requirements
See related substances.
Assay
Accurately measure the test solution and the reference solution, respectively inject them into the liquid chromatograph, and record the chromatogram.Calculate by peak area according to external standard method.